PlantEXT

PlantEXT is a private Israeli-Canadian pharmaceutical cannabis company developing clinically supported cannabinoid- and terpene-based formulations for inflammation-related conditions. The company applies a pharma-style product development approach, including molecular-level characterization, in-vitro and ex-vivo testing, and Quality by Design principles, to create reproducible medical cannabis products that are not strain dependent. Its disclosed pipeline includes products for inflammatory bowel disease, dermatologic inflammation such as psoriasis and atopic dermatitis, and pain-related conditions including arthritis and migraine. PlantEXT has also highlighted research related to lung inflammation and COVID-19-associated cytokine storm, and has referenced addiction-focused R&D tied to the endocannabinoid system. The company has worked with Israel's Agricultural Research Organization (Volcani Center) and presents itself as focused on commercializing clinically evidenced anti-inflammatory cannabis formulations globally.